Irmarie Mendez Velez, MRC | |
8 Calle Rius Rivera Apt 3, Adjuntas, PR 00601-2335 | |
(787) 601-1740 | |
Not Available |
Full Name | Irmarie Mendez Velez |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 8 Calle Rius Rivera Apt 3, Adjuntas, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104583855 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | 1583 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Irmarie Mendez Velez, MRC Po Box 851, Adjuntas, PR 00601-0851 Ph: (787) 601-1740 | Irmarie Mendez Velez, MRC 8 Calle Rius Rivera Apt 3, Adjuntas, PR 00601-2335 Ph: (787) 601-1740 |
News Archive
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
Microbes that live in rice paddies, northern peat bogs and other previously unexpected environments are among the bacteria that can generate highly toxic methylmercury, researchers at Oak Ridge National Laboratory and the Smithsonian Environmental Research Center have learned.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
K-V Pharmaceutical Company today announced that it has entered into a definitive agreement with a group of institutional investors to raise approximately $32 million of gross proceeds from a private placement of 9,950,000 shares of its Class A Common Stock at $3.25 per share.
› Verified 7 days ago
Mrs. Joan Ivelisse Rosado Vargas, MRC Counselor Medicare: Not Enrolled in Medicare Practice Location: Bo Garzas, Carr 10 Km 0.4, Adjuntas, PR 00601 Phone: 787-967-8483 |